Initial Evaluation of Suspected Iron‑Deficiency Anemia in Adolescents

Laboratory Assessment

• The presence of microcytic anemia with an elevated red‑cell distribution width (RDW) is a hallmark of iron‑restricted erythropoiesis and strongly points to iron deficiency. National Comprehensive Cancer Network (NCCN) recommendations support this interpretation. 4
• An elevated RDW helps differentiate iron deficiency from thalassemia trait, which typically shows a normal RDW despite low MCV. Centers for Disease Control and Prevention (CDC) guidance notes this distinction. 6
• Serum ferritin is the single most powerful test for detecting iron deficiency. NCCN lists ferritin as the primary screening laboratory. 7
• In adolescents without evidence of inflammation, a ferritin level < 15–30 µg/L confirms iron deficiency. CDC criteria define this cutoff. 9
• When inflammation is present (elevated C‑reactive protein), ferritin values up to 100 µg/L may still indicate iron deficiency. CDC advises interpreting ferritin in the context of acute‑phase reactants. 1
• Transferrin saturation (TSAT) < 15–16 % supports a diagnosis of iron deficiency. NCCN recommends this threshold. 4
• A reticulocyte index < 2.0 (low or inappropriately normal) signals reduced red‑cell production consistent with iron deficiency. NCCN includes this as a key marrow‑response indicator. 4
• Conversely, an elevated reticulocyte count suggests active blood loss or hemolysis and warrants a different diagnostic pathway. NCCN highlights this as a red‑flag. 2
• C‑reactive protein (CRP) measurement is required to correctly interpret ferritin when inflammation may be present. CDC recommends routine CRP alongside ferritin. 1

Peripheral Blood Smear

• Review of the peripheral smear is essential to confirm microcytosis, assess hypochromia and anisocytosis, and to exclude alternative etiologies such as thalassemia or sideroblastic anemia. NCCN emphasizes smear examination as a core component of the work‑up. 10

Clinical History Elements

• Detailed dietary assessment—including intake of iron‑rich foods, fortified products, and restrictive eating patterns—is necessary to identify inadequate iron consumption. CDC nutrition guidelines advise this evaluation. 11
• In post‑menarchal females, a menstrual history focusing on heavy or prolonged bleeding is a primary risk factor for iron deficiency. NCCN recommends systematic menstrual inquiry. 4
• Gastrointestinal symptoms (e.g., occult blood in stool, abdominal pain, diarrhea) may indicate malabsorption or chronic blood loss and should be explored. NCCN lists these as red‑flag symptoms. 7
• Use of NSAIDs, aspirin, or proton‑pump inhibitors can impair iron absorption or cause gastrointestinal bleeding; medication review is therefore required. NCCN includes medication assessment in the history. 8
• A family history of thalassemia or other hereditary anemias guides further testing. NCCN recommends documenting hereditary risk. 5
• Ethnicity influences the prevalence of thalassemia traits (higher in Mediterranean, Asian, and African populations) and should inform differential diagnosis. CDC epidemiologic data support this consideration. 6

Physical Examination Findings

• Signs of pallor, tachycardia, and, in severe cases, heart‑failure manifestations are typical of significant anemia. NCCN lists these as common physical findings. 5
• Jaundice or splenomegaly point toward hemolysis rather than iron deficiency and should prompt alternative work‑up. NCCN cautions against misattributing these signs. 5
• Neurologic deficits would suggest vitamin B12 deficiency and are not expected in isolated iron deficiency. NCCN notes this distinction. 4
• Evidence of gastrointestinal pathology (e.g., abdominal tenderness, masses) may indicate a source of chronic blood loss. NCCN recommends targeted abdominal examination. 7

Diagnostic Algorithm

• Ferritin < 30 µg/L and TSAT < 15 % (no inflammation) → iron‑deficiency anemia confirmed; proceed to identify the underlying cause. NCCN algorithm. 8
• Ferritin 30–100 µg/L with elevated CRP → likely iron deficiency coexisting with inflammation (anemia of chronic disease component); consider soluble transferrin receptor or reticulocyte‑hemoglobin content for clarification. CDC guidance. 3
• Ferritin > 100 µg/L → iron deficiency unlikely; evaluate for anemia of chronic disease, thalassemia, or other etiologies; hemoglobin electrophoresis is advised to exclude thalassemia. NCCN recommendation. 6

Identifying the Underlying Cause

• In females with heavy menstrual bleeding, prioritize menstrual assessment as the most common source of iron loss. CDC recommendations. 11
• For males or when menstrual loss is insufficient to explain anemia, gastrointestinal evaluation is indicated: stool guaiac testing, Helicobacter pylori testing, celiac serology, and endoscopic investigation as needed. NCCN outlines this stepwise approach. 8
• Dietary insufficiency—particularly in vegetarian or restricted diets and excessive cow’s milk (> 24 oz/day)—should be addressed with nutritional counseling. CDC nutrition guidance. 11

Extended Work‑Up (When Initial Tests Are Inconclusive)

• Measure vitamin B12 and folate to exclude combined deficiencies that could mask iron deficiency. NCCN includes these assays in the extended panel. 2
• Assess lead levels if environmental exposure is suspected, as lead can cause microcytic anemia. CDC environmental health guidelines. 6
• Perform hemoglobin electrophoresis to definitively rule out thalassemia trait when iron studies are equivocal. NCCN recommends this confirmatory test. 6
• Refer to hematology for complex cases or when bone‑marrow pathology is a concern. Clinical Gastroenterology and Hepatology advises specialist consultation. 8

Common Pitfalls to Avoid

• Do not assume all microcytic anemia is iron deficiency; thalassemia trait often presents with normal RDW and elevated RBC count. NCCN warns against this oversimplification. 6
• Do not rely on hemoglobin/hematocrit alone for screening; tissue iron depletion precedes changes in these values. CDC emphasizes early iron‑store testing. 9
• Do not misinterpret ferritin in the presence of inflammation; it is an acute‑phase reactant and may be falsely elevated. NCCN and CDC both stress concurrent CRP measurement. 3
• Do not overlook celiac disease as a cause of iron deficiency in adolescents with gastrointestinal symptoms; appropriate serologic testing is recommended. Clinical Gastroenterology and Hepatology highlights this association. 8
• Do not start empiric iron therapy without confirming the diagnosis in adolescents; a full evaluation is needed to identify the true etiology and avoid unnecessary treatment. CDC advises diagnostic confirmation before therapy. 11